Alector (ALEC) Change in Account Payables (2018 - 2026)
Alector (ALEC) reported Change in Account Payables of -$268000.0 for Q1 2026, down 341.44% year-over-year from $111000.0 in Q1 2025, and up 91.26% quarter-over-quarter from -$3.1 million in Q4 2025.
Alector (ALEC) Change in Account Payables (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Change in Account Payables data on file, last reported at -$268000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$268000.0, down 341.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$903000.0 (up 59.83% YoY), and the FY2025 annual result was -$524000.0, up 63.64% from the prior year.
- Change in Account Payables advanced to -$268000.0 in Q1 2026 per ALEC's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.5 million in Q3 2025 and troughed at -$3.1 million in Q4 2025.
- A 5-year average of -$187176.5 and a median of -$109000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables tumbled 437.04% in 2023, then soared 17150.0% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$189000.0 in 2022, then plunged by 437.04% to -$1.0 million in 2023, then tumbled by 173.3% to -$2.8 million in 2024, then decreased by 10.53% to -$3.1 million in 2025, then jumped by 91.26% to -$268000.0 in 2026.
- Business Quant data shows ALEC's Change in Account Payables at -$268000.0 in Q1 2026, -$3.1 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -268,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -268,000.00 |
| Mar 31, 2026 | -268,000.00 |
| Dec 31, 2025 | -3.07 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | -109,000.00 |
| Jun 30, 2025 | -109,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 690,000.00 |
| Sep 30, 2024 | 690,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Mar 31, 2024 | 918,000.00 |
| Mar 31, 2024 | 918,000.00 |
| Dec 31, 2023 | -1.02 Mn |
| Dec 31, 2023 | -1.02 Mn |